New C. Difficile Guidance Recommends Fecal Microbiota Transplantation in Adults with Recurrent Infections
February 23, 2018 | Aging Services Risk, Quality, & Safety Guidance
The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America have updated guidelines for treating Clostridium difficile infections, significantly changing the recommendations for adults. The update, published online February 15, 2018, in Clinical Infectious Diseases, recommends adult patients with any type of infection—whether mild or severe, first-time or recurring—adhere to a minimum 10-day course of vancomycin or fidaxomicin instead of metronidazole. Evidence shows fidaxomicin, a newly recommended medication for C. difficile infections, may also reduce repeat episodes in adults with mild to moderate cases, which occur in about 25% of patients.